{"name":"HALEON US HOLDINGS","slug":"haleon-us-holdings","ticker":"","exchange":"","domain":"haleonus.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":3100000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Arnuity Ellipta","genericName":"FLUTICASONE FUROATE","slug":"fluticasone-furoate","revenue":3100000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"2004-01-01","label":"Excedrin Extra Strength Pain Reliever first approved","drug":"Excedrin Extra Strength Pain Reliever","drugSlug":"nsaid","type":"approval","sentiment":"positive"},{"date":"2007-01-01","label":"Arnuity Ellipta first approved","drug":"Arnuity Ellipta","drugSlug":"fluticasone-furoate","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":3100000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Arnuity Ellipta","genericName":"FLUTICASONE FUROATE","slug":"fluticasone-furoate","indication":"Nasal Congestion Relief","status":"marketed","revenue":3100000000}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Excedrin Extra Strength Pain Reliever","genericName":"NSAID","slug":"nsaid","indication":"headache","status":"marketed"}]}],"pipeline":[{"name":"Arnuity Ellipta","genericName":"FLUTICASONE FUROATE","slug":"fluticasone-furoate","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Nasal Congestion Relief","Runny Nose Relief","Sneezing Relief","Itchy Nose Relief","Itchy, Watery Eyes Relief"],"catalyst":""},{"name":"Excedrin Extra Strength Pain Reliever","genericName":"NSAID","slug":"nsaid","phase":"marketed","mechanism":"Cyclooxygenase","indications":["headache","cold","arthritis","muscular aches","toothache"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}